Sensus Healthcare Stock

Sensus Healthcare EBITDA per Share

The EBITDA per Share of Sensus Healthcare (SRTS) as of Aug 10, 2026 is -0.63 USD. In the previous year, EBITDA per Share was 0.49 USD — a change of -228.30% (lower).

EBITDA per Share

-0.63USD

YoY

-228.30%

Last updated:

EBITDA per Share of Sensus Healthcare is 2026 -0.63 USD. EBITDA per Share of Sensus Healthcare was 2025 0.49 USD. It decreases by -228.30% lower compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Sensus Healthcare Stock analysis

What does Sensus Healthcare do? Sensus Healthcare Inc is a US-based medical technology company specializing in the development, manufacturing, and distribution of medical devices for non-invasive treatment of skin cancer and other skin conditions. The company was founded in 2010 by Kalman Fishman and is headquartered in Boca Raton, Florida. Sensus Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sensus Healthcare stock

EBITDA per Share of Sensus Healthcare is -0.63 USD in 2026.

EBITDA per Share of Sensus Healthcare changed from 0.49 USD to -0.63 USD, representing a -228.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Sensus Healthcare since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Sensus Healthcare

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sensus Healthcare